Effect of Backing Films on the Transdermal Delivery of Donepezil from Patches

Ageing International

Volumn 15, Issue 6, 2014, Pages 1569-1573

  Liu, Nannan ^a   Zhang, Yaqiong ^a   Cun, Dongmei ^a   Quan, Peng ^a   Fang, Liang ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

ATR FTIR; backing films; donepezil; release; transdermal patches

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; EXCIPIENT; INDAN DERIVATIVE; PIPERIDINE DERIVATIVE; WATER;

ANIMAL; CHEMISTRY; COMPARATIVE STUDY; CUTANEOUS DRUG ADMINISTRATION; DIFFERENTIAL SCANNING CALORIMETRY; INFRARED SPECTROSCOPY; KINETICS; MEDICINAL CHEMISTRY; METABOLISM; PERMEABILITY; PHARMACEUTICS; PILOT STUDY; PROCEDURES; RABBIT; SKIN; SKIN ABSORPTION; SOLUBILITY; TRANSDERMAL PATCH;

ADMINISTRATION, CUTANEOUS; ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CHOLINESTERASE INHIBITORS; EXCIPIENTS; INDANS; KINETICS; PERMEABILITY; PILOT PROJECTS; PIPERIDINES; RABBITS; SKIN; SKIN ABSORPTION; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TECHNOLOGY, PHARMACEUTICAL; TRANSDERMAL PATCH; WATER;

EID: 84912108045     PISSN: 01635158     EISSN: 1936606X     Source Type: Journal    
DOI: 10.1208/s12249-014-0190-z     Document Type: Article

References (19)

1. Asiri YA, Mostafa GAE. Donepezil. Profiles Drug Subst Excip Relat Methodol. 2010;35:117–50.
2. Liew KB, Tan YTF, Peh KK. Characterization of oral disintegrating film containing donepezil for Alzheimer disease. AAPS PharmSciTech. 2012;13:134–42.
3. Heydorn WE. Donepezil (E2020): a new acetylcholinesterase inhibitor. Review of its pharmacology, pharmacokinetics, and utility in the treatment of Alzheimer’s disease. Expert Opin Invistig Drugs. 1997;6:1527–35.
4. Sozio P, Cerasa LS, Marinelli L, Stefano AD. Transdermal donepezil on the treatment of Alzheimer’s disease. Neuropsychiatr Dis Treat. 2012;8:361–8.
5. Sun L, Cun DM, Yuan B, Cui HX, Xi HL, Fang L, et al. Formulation and in vitro/in vivo correlation of a drug-in-adhesive transdermal patch containing azasetron. J Pharm Sci. 2012;101:4540–8.
6. Stoughton RB. Percutaneous absorption of drugs. Annu Rev Pharmacol Toxicol. 1989;29:55–69.
7. Thein-Han WW, Stevens WF. Transdermal delivery controlled by a chitosan membrane. Drug Dev Ind Pharm. 2004;30:397–404.
8. Suksaeree J, Boonme P, Taweepreda W, Ritthidej GC, Pichayakorn W. Characterization, in vitro release and permeation studies of nicotine transdermal patches prepared from deproteinized natural rubber latex blends. Chem Eng Res Des. 2012;90:906–14.
9. Arunan E, Desiraju GR, Klein RA, Sadlej J, Scheiner S, Alkorta I, et al. Defining the hydrogen bond: an account (IUPAC Technical Report). Pure Appl Chem. 2011;83:1619–36.
10. Hirashima Y, Sato H, Suzuki A. ATR-FTIR spectroscopic study on hydrogen bonding of poly(N-isopropylacrylamide-co-sodium acrylate) gel. Macromolecules. 2005;38:9280–6.
11. Kollman PA, Allen LC. Theory of the hydrogen bond. Chem Rev. 1972;72:283–303.
12. Steiner T. The hydrogen bond in the solid state. Angew Chem Int Ed Engl. 2002;41:48–76.
13. Coleman MM, Skrovanek DJ, Hu J, Painter PC. Hydrogen bonding in polymer blends. 1. FTIR studies of urethane-ether blends. Macromolecules. 1988;21:59–65.
14. Mattia J, Painter P. A comparison of hydrogen bonding and order in a polyurethane and poly(urethane-urea) and their blends with poly(ethylene glycol). Macromolecules. 2007;40:1546–54.
15. Huheey JE. The electronegativity of groups. J Phys Chem. 1965;69:3284–91.
16. Xi HL, Cun DM, Wang ZY, Shang L, Song WT, Fang L, et al. Effect of the stability of hydrogen-bonded ion pairs with organic amines on transdermal penetration of teriflunomide. Int J Pharm. 2012;436:857–61.
17. Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2012;64:128–37.
18. Thomas S, Fear M, Humphreys J, Disley L, Waring MJ. The effect of dressings on the production of exudate from venous leg ulcers. Wounds. 1996;8:145–50.
19. Zhai HB, Maibach HI. Occlusion vs. skin barrier function. Skin Res Tech. 2002;8:1–6.